Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Workman

Showing results (251-260 of 315) with videos related to

Pageof 32
Sort By:
Plos One|January 19, 2012
Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signallingSimon R Stockwell, Georgina Platt, S Elaine Barrie, et al.
Cancer Research|July 9, 2010
A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcriptionKenneth Ewan, Bozena Pajak, Mark Stubbs, et al.
Nature Communications|February 14, 2025
Structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapyJoseph A Newman, Angeline E Gavard, Nergis Imprachim, et al.
Cancer Discovery|March 30, 2013
Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCNLynn Bjerke, Alan Mackay, Meera Nandhabalan, et al.
Plos One|April 15, 2009
Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug developmentDorine A Bax, Suzanne E Little, Nathalie Gaspar, et al.
NAR Cancer|March 16, 2026
Human DEAH-box helicase 8 regulates HSF1-mediated stress response and cancer-associated pre-mRNA splicing in tumour cellsJennifer R Tall, Robert Te Poele, Alexandra Vasile, et al.
Molecular Cancer Therapeutics|April 29, 2010
AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growthKyla M Grimshaw, Lisa-Jane K Hunter, Timothy A Yap, et al.
Journal of Medicinal Chemistry|December 15, 2017
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)Nicola E A Chessum, Swee Y Sharp, John J Caldwell, et al.
Nucleic Acids Research|November 13, 2024
canSAR 2024-an update to the public drug discovery knowledgebasePhillip W Gingrich, Rezvan Chitsazi, Ansuman Biswas, et al.
Bioorganic & Medicinal Chemistry|October 11, 2011
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitorsStuart C Wilson, Butrus Atrash, Clare Barlow, et al.
Pageof 32

Showing results (251-260 of 315) with videos related to

Sort By:
Pageof 32
Plos One|January 19, 2012
Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signallingSimon R Stockwell, Georgina Platt, S Elaine Barrie, et al.
Cancer Research|July 9, 2010
A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcriptionKenneth Ewan, Bozena Pajak, Mark Stubbs, et al.
Nature Communications|February 14, 2025
Structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapyJoseph A Newman, Angeline E Gavard, Nergis Imprachim, et al.
Cancer Discovery|March 30, 2013
Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCNLynn Bjerke, Alan Mackay, Meera Nandhabalan, et al.
Plos One|April 15, 2009
Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug developmentDorine A Bax, Suzanne E Little, Nathalie Gaspar, et al.
NAR Cancer|March 16, 2026
Human DEAH-box helicase 8 regulates HSF1-mediated stress response and cancer-associated pre-mRNA splicing in tumour cellsJennifer R Tall, Robert Te Poele, Alexandra Vasile, et al.
Molecular Cancer Therapeutics|April 29, 2010
AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growthKyla M Grimshaw, Lisa-Jane K Hunter, Timothy A Yap, et al.
Journal of Medicinal Chemistry|December 15, 2017
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)Nicola E A Chessum, Swee Y Sharp, John J Caldwell, et al.
Nucleic Acids Research|November 13, 2024
canSAR 2024-an update to the public drug discovery knowledgebasePhillip W Gingrich, Rezvan Chitsazi, Ansuman Biswas, et al.
Bioorganic & Medicinal Chemistry|October 11, 2011
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitorsStuart C Wilson, Butrus Atrash, Clare Barlow, et al.
Pageof 32